TVGN News

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Letter to Shareholders from CEO Dr. Ryan Saadi

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

Form 8-K

Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth

Form 8-K

Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)

Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization